RETRACTED ARTICLE: Tiliroside as a CAXII inhibitor suppresses liver cancer development and modulates E2Fs/Caspase-3 axis

Rui Han(Guangzhou University of Chinese Medicine), Lizhu Lin(First Affiliated Hospital of Guangzhou University of Chinese Medicine)
Scientific Reports
April 21, 2021
10.1038/s41598-021-88133-7
Cited by 42

Related Papers

Tanshinone IIA combined with cisplatin synergistically inhibits non‐small‐cell lung cancer in vitro and in vivo via down‐regulating the phosphatidylinositol 3‐kinase/Akt signalling pathway
|Phytotherapy Research|2019|64
Valeric acid acts as a novel HDAC3 inhibitor against prostate cancer
|Medical Oncology|2022|30
RETRACTED ARTICLE: Weipiling ameliorates gastric precancerous lesions in Atp4a−/− mice
|BMC Complementary and Alternative Medicine|2019|14
Cordycepin Reverses Cisplatin Resistance in Non-Small Cell Lung Cancer by Activating AMPK and Inhibiting the AKT Signaling Pathway
|Research Square (Research Square)|2020|0